RPGLIFE
RPG Life Sciences Limited (RPGLIFE) Stock Analysis
RPG Life Sciences Limited develops and markets pharmaceuticals in cardiology, diabetes, and primary care segments. It manufactures formulations for India and exports. The company is part of the RPG group healthcare business. It is listed on Indian stock exchanges.
Healthcare › Drug Manufacturers - Specialty & Generic
₹2,719.20
-7.22% 1W | +27.60% 52W
Market Cap
4.5k CR
P/E Ratio
37.6
52W High
₹3127.8
52W Low
₹1733
Div. Yield
0.85%
Beta
-0.1
50 DMA
₹2753.8
200 DMA
₹2331.4
Profit Margin
16.3%
Inst. Own.
5.6%
📊 CONSOLIDATION
⚡ APPROACHING SUPPORT
Fundamentals
Profit & Loss
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 173 | 143 | 169 | 182 | 180 | 177 | 196 |
| Expenses | 124 | 118 | 133 | 143 | 140 | 144 | 152 |
| Operating Profit | 49 | 25 | 35 | 39 | 40 | 33 | 43 |
| OPM % | 28% | 18% | 21% | 21% | 22% | 19% | 22% |
| Other Income | 3 | 115 | 5 | 16 | -5 | 14 | 5 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Depreciation | 5 | 5 | 5 | 5 | 5 | 6 | 6 |
| Profit before tax | 47 | 135 | 35 | 49 | 29 | 40 | 41 |
| Tax % | 26% | 13% | 26% | 25% | 24% | 26% | 26% |
| Net Profit | 35 | 117 | 26 | 37 | 22 | 30 | 31 |
| EPS in Rs | 21.12 | 70.95 | 15.90 | 22.28 | 13.38 | 18.08 | 18.60 |
| Metric | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|
| Sales | 653 | 708 | 734 |
| Expenses | 493 | 560 | 579 |
| Operating Profit | 161 | 148 | 155 |
| OPM % | 25% | 21% | 21% |
| Other Income | 95 | 29 | 29 |
| Interest | 2 | 2 | 1 |
| Depreciation | 21 | 21 | 22 |
| Profit before tax | 233 | 154 | 160 |
| Tax % | 21% | 25% | |
| Net Profit | 183 | 115 | 120 |
| EPS in Rs | 110.79 | 69.64 | 72.34 |
| Dividend Payout % | 22% | 34% |
Shareholding Pattern
Promoters72.95%
FIIs1.11%
DIIs6.70%
Public19.23%
Promoters72.95%
FIIs1.00%
DIIs7.04%
Public19.01%
Promoters72.95%
FIIs0.87%
DIIs7.45%
Public18.72%
Promoters72.95%
FIIs0.95%
DIIs8.68%
Public17.42%
Promoters72.95%
FIIs0.87%
DIIs9.93%
Public16.24%
Promoters72.82%
FIIs0.38%
DIIs0.11%
Public26.70%
Promoters72.82%
FIIs0.90%
DIIs2.16%
Public24.12%
Promoters72.95%
FIIs1.46%
DIIs6.14%
Public19.46%
Promoters72.95%
FIIs0.87%
DIIs7.45%
Public18.72%
Promoters72.95%
FIIs0.87%
DIIs9.93%
Public16.24%
RPGLIFE
Holdings Analysis
Key strengths & risk signals
75
Overall
75
Fundamental
75
Technical
Risks (3)
NEGLIGIBLE DIVIDEND! 0.85% yield - little to no income.
RECOVERY MODE! Current price (2719.2) above 200-day but below 50-day.
NEGATIVE MOMENTUM! Price declined across timeframes - down 7.2% (1 week), 3.3% (1 month), 4.8% (3 months).
Strengths (4)
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
BULLISH TREND! 50-day average (2753.8) is above 200-day average (2331.4) - positive signal.
BULLISH SENTIMENT! In last 30 days: 12 up days, 18 down days. Avg volume on up days: 50,499 vs down days: 21,411. Ratio: 2.36x
LOW VOLATILITY! Beta of -0.10 - stable stock, less market risk.
Fundamental & Technical Analysis
75Overall
75Fundamental
75Technical
Fundamental Breakdown
Growth Quality
24/30
Revenue CAGR: 11.3% (GOOD, 11/15). Profit CAGR: 19.4% (VERY GOOD, 13/15).
Profit Margin
6/10
GOOD EFFICIENCY! 16.3% profit margin - above average profitability.
PEG Valuation
8/10
FAIRLY VALUED! PEG of 1.94 indicates reasonable valuation.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0.85% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.24 - excellent financial health.
Public Holding
14/20
MODERATE PUBLIC HOLDING! 26.58% public ownership - balanced ownership structure.
Stability Index
10/10
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
Technical Breakdown
Moving Averages
12/10
BULLISH TREND! 50-day average (2753.8) is above 200-day average (2331.4) - positive signal.
Price Position
2/10
RECOVERY MODE! Current price (2719.2) above 200-day but below 50-day.
Trend Pattern
10/20
TESTING SUPPORT! Stock is at key support level.
52W Performance
8/10
GOOD YEAR! Stock gained 27.6% in the last year.
Volume Sentiment
30/30
BULLISH SENTIMENT! In last 30 days: 12 up days, 18 down days. Avg volume on up days: 50,499 vs down days: 21,411. Ratio: 2.36x
RSI
3/5
NEUTRAL! RSI at 44.0 - balanced momentum.
52W Range
4/5
UPPER HALF! Trading at 70.7% of 52W range - positive territory.
Momentum
1/5
NEGATIVE MOMENTUM! Price declined across timeframes - down 7.2% (1 week), 3.3% (1 month), 4.8% (3 months).
Beta
5/5
LOW VOLATILITY! Beta of -0.10 - stable stock, less market risk.
RPGLIFE
Concall / Investor Presentation
Earnings call transcripts & AI summaries
| Quarter | Concall | Summary |
|---|---|---|
| Q4FY262026-05-08 | Concall PDF | |
| Q1FY262025-10-24 | Concall PDF |
Peer Comparison
Healthcare · Drug Manufacturers - Specialty & Generic · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RPGLIFE | ₹2,719.20 | 37.6 | 16.3% | 11.3% | 19.4% | +27.6% | 75 | APPROACHING SUPPORT | +17.1% | +3.0% | +15.9% | +10.6% |
| GUJTHEM | ₹363.50 | 81.3 | 28.0% | 3.8% | -7.0% | -9.7% | 58 | BREAKDOWN | +22.0% | +1.8% | +22.0% | -0.9% |
| GUFICBIO | ₹406.30 | 55.5 | 7.5% | 6.1% | -6.9% | +15.7% | 60 | BREAKDOWN | +70.2% | +1.8% | +16.6% | +3.6% |
| ORCHPHARMA | ₹984.00 | 611.1 | 3.5% | 22.3% | -40.1% | +37.3% | 67 | APPROACHING RESISTANCE | -156.1% | -86.6% | +15.6% | +28.0% |
| AARTIDRUGS | ₹413.30 | 19.7 | 7.1% | -2.3% | 5.4% | -17.9% | 57 | BOUNCE FROM SUPPORT | -6.9% | -9.1% | +19.0% | -2.4% |
| UNICHEMLAB | ₹531.10 | 12.3 | 13.2% | 18.4% | – | +12.3% | 64 | BREAKDOWN | -495.2% | +280.7% | +20.1% | +10.0% |
| SOLARA | ₹644.40 | – | -0.1% | -1.2% | – | +14.8% | 53 | CONSOLIDATING DOWN | +55.2% | +69.8% | +19.5% | -1.5% |
| INDSWFTLAB | ₹360.90 | 53.9 | 8.5% | -19.7% | -3.2% | +249.6% | 59 | BREAKDOWN | +180.7% | +63.6% | +21.0% | +12.8% |
Data from TradeAlone · Updated daily
